期刊文献+

96例噬血细胞综合征儿童外周血CD4^+T细胞亚群、淋巴细胞亚群分析 被引量:4

Analysis of peripheral blood CD4^+T lymphocyte subsets and lymphocyte subsets in 96 children with hemophagocytic syndrome
下载PDF
导出
摘要 目的:探究噬血细胞综合征(hemophagocytic syndrome,HPS)患儿外周血CD4+T细胞亚群及淋巴细胞亚群的变化及意义。方法:选取2010年2月至2017年1月郑州大学附属儿童医院血液肿瘤科收治的96例HPS患儿为研究对象(HPS组),入院后按照相关推荐方案实施化学治疗(简称化疗),根据治疗效果将患儿分为预后良好组与预后不良组。另选40名同期入院体检的健康儿童作为对照组。HPS患儿于就诊第2天、治疗结束后,对照组于体检当天清晨采集空腹静脉血,采用流式细胞仪测定外周血CD4^+T细胞亚群Th1,Th2,Th17,Treg,淋巴细胞亚群CD3^+,CD4^+,CD8^+,CD19^+。结果:与对照组相比,HPS组Th2,Th17,Th17/Treg比值均明显升高,Th1/Th2比值、Treg明显降低;且CD3^+,CD8+明显升高,CD4^+,CD4^+/CD8^+比值明显降低,差异均有统计学意义(P<0.05);CD19^+水平差异无统计学意义(P>0.05)。HPS组经3个阶段的化疗后,26例(27.08%)有效、36例(37.50%)疾病缓解、7例(7.29%)疾病活动、3例(3.13%)疾病复发、24例(25.00%)死亡。与预后良好组患儿相比,预后不良组患儿Th2,Th17,Th17/Treg比值均明显升高,Th1/Th2比值、Treg明显降低;且CD3^+,CD8^+明显升高,CD4^+,CD4^+/CD8^+比值明显降低,差异均有统计学意义(P<0.05);CD19^+差异无统计学意义(P>0.05)。结论:HPS儿童存在外周血CD4^+T细胞亚群及T细胞亚群异常,可用于评估患儿免疫功能损害及判断其预后。 Objective:To analyze the changes and significance of CD4^+T lymphocyte subsets and lymphocyte subsets in peripheral blood of 96 children with hemophagocytic syndrome(HPS).Methods:A total of 96 children with HPS who were admitted to the department of hematology and oncology of the hospital from February 2010 to January 2017 were selected as the subjects(HPS group).They were treated with chemotherapy after admission according to the relevant recommended regimen.According to the therapeutic effect,the children were divided into a good prognosis group and a poor prognosis group;40 healthy children admitted to the hospital at the same time were selected as a control group.The fasting venous blood of children with HPS was collected at the 2nd day after the admission and after the end of treatment,while the fasting venous blood of the control group was collected in the morning on the day of physical examination.The peripheral blood CD4^+T cell subsets Th1,Th2,Th17 and Treg,lymphocyte subsets CD3^+,CD4^+,CD8^+ and CD19^+ were determined by flow cytometry.Results:The Th2,Th17 and Th17/Treg,CD3^+ and CD8^+ were significantly higher,while Th1/Th2 and Treg,CD4^+ and CD4^+/CD8^+ were significantly lower in HPS group than in the control group(P<0.05),there was no significant difference in CD19+between the two groups(P>0.05).After three stages of chemotherapy,26 cases(27.08%)were effectively treated,36 cases(37.50%)were relieved,7 cases(7.29%)had disease activity,3 cases(3.13%)had recurrence,and 24 cases(25.00%)died.The Th2,Th17 and Th17/Treg,CD3^+ and CD8^+ were significantly higher,while Th1/Th2 and Treg,CD4^+ and CD4^+/CD8^+ were significantly lower in the poor prognosis group than in the good prognosis group(P<0.05),there was no significant difference in CD19^+ between the two groups(P>0.05).Conclusion:Children with HPS have abnormal CD4^+T cells subsets and T cell subsets in peripheral blood,which can be used to evaluate the damage of immune function and prognosis in children.
作者 高海丽 刘炜 田亮 GAO Haili;LIU Wei;TIAN Liang(Department of Blood Oncology,Affiliated Children’s Hospital of Zhengzhou University(Henan Children’s Hospital,Zhengzhou Children’s Hospital),Zhengzhou 450000,China)
出处 《临床与病理杂志》 2019年第11期2394-2400,共7页 Journal of Clinical and Pathological Research
基金 河南省科技发展项目(122102310449)~~
关键词 噬血细胞综合征 儿童 CD4^+T细胞亚群 T细胞亚群 hemophagocytic syndrome children CD4^+T cell subsets T cell subsets
  • 相关文献

参考文献14

二级参考文献111

  • 1秦刚,陈明泉,施光峰,翁心华.成人传染性单核细胞增多症21例[J].中华传染病杂志,2006,24(3):192-193. 被引量:15
  • 2李欣,徐酉华.EB病毒相关性噬血细胞综合征的研究进展[J].国际儿科学杂志,2007,34(5):328-331. 被引量:8
  • 3James W V, William J G. Hemophagocytic lymphohistiocytosis : di- agnosis, pathophysiology, treatment, and future perspectives [ J ]. Ann Med,2006,38 ( 1 ) :20 - 31.
  • 4Jeffrey A. The yin and yang of interleukin-2-mediated immunother- apy[J] . N Engl J Med, 2011,365(22) :2129 -31.
  • 5Gupta S, Weitzman S. Primary and secondary hemophagocytic lym- phohistiocytosis : clinical features, pathogenesis and therapy [ J ]. Expert Rev Clin Immuno1,2010,6 ( 1 ) : 137 - 54.
  • 6Boyman O,Sprent J. The role of interleukin 2 during homeostasis and activation of the immune system [ J ]. Nature Reviews Immu- nology,2012,12(3) :180 -90.
  • 7Malek T R. The biology of interleukin-2 [ J]. Annu Rev Immunol. 2008, 26:453 - 79.
  • 8Saadoun D,Rosenzwajg M,Joly F,et al. Regulatory T-cell respon- ses to low-dose interleukin-2 in HCV-induced vasculitis[ J ]. N En- gl J Med ,2011,365 ( 22 ) :2067 - 77.
  • 9Fehniger T A, Bluman E M, Porter M M, et al. Potential mecha- nisms of human natural killer cell expansion in vivo during low- dose IL-2 therapy [ J ]. J Clin Invest,2000,106 ( 1 ) : 117 - 24.
  • 10Henter JI,Home A,Arico M. HLH-2004:Diagnostic and therapeutic Guideline for hemophagocytic lymphohistiocytosis[J].Pediatric Blood & Cancer,2007.124-131.

共引文献115

同被引文献47

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部